A study by scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), the Universidad Complutense (UCM), Universidad de Girona (UdG), and the Institute for Bioengineering of Catalonia (IBEC), working together with other international centers, has overcome one of the key hurdles to the use of nanorobots powered by enzymes called lipases.
Application Deadline: 01/11/2020
Ref: SR-EM
The The Biomimetic Systems for cell engineering group at the Institute for Bioengineering of Catalonia (IBEC) Group is looking for a Senior Postdoctoral Researcher to work on the development and optimization of a new fabrication platform based on 3D printing, with integrated microfluidics and environmental control.
The contract will be within the framework of the GUT3D-PLATE project; a Proof of Concept project granted by the European Research Council (ERC), whose objective is the fabrication of ready-to-commercialize 3D cell culture scaffolds mimicking the intestinal physiology.
Emmanuelle Charpentier and Jennifer Doudna have been awarded the Nobel Prize in Chemistry 2020 for discovering a gene technology in Bioengineering: the CRISPR/Cas9 genetic scissors. The announcement marks the first time a science Nobel has been awarded to two women.
.
Application Deadline: 31/10/2020
Ref: LT-EM
The The Biomimetic Systems for cell engineering group at the Institute for Bioengineering of Catalonia (IBEC) is looking for Technical Support to Research to work on the optimization and customization of a 3D printing device to obtain 3D cell culture substrates.
The contract will be within the framework of the GUT3D-PLATE project; a Proof of Concept project granted by the European Research Council (ERC), whose objective is the fabrication of ready-to-commercialize 3D cell culture scaffolds mimicking the intestinal physiology.
Did you know that cells feel their surrounding and “communicate” with one another? Cells move and form tissues and organs, and to do so, they need to interact with each … Read more
Under the name of “Modern approaches for developing antivirals against SARS-CoV 2” (MAD-CoV 2) the project focuses on the development and delivery of therapeutic tools for the current COVID-19 outbreak.